Alpine Global Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Alpine Global Management’s Portfolio ITCI Stock Details ITCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-50,000	Closed	-$6.6M	–	222
2025 Q1	$6.6M	Buy	+50,000	New	+$6.23M	1.75%	14
2024 Q3	–	Sell	-35,300	Closed	-$2.42M	–	507
2024 Q2	$2.42M	Buy	+35,300	New	+$2.45M	0.42%	51

Other funds holding ITCI

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

KIM

Kestra Investment Management Austin, Texas $5.8B AUM 14.71% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Alpine Global Management's ITCI Position: Q2 2025 in Review

Alpine Global Management sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2025, closing a stake of 50,000 shares — an estimated $6.6M sold.

Alpine Global Management first reported a position in ITCI in Q2 2024 and held it in 2 quarters. The position peaked at $6.6M in Q1 2025. 4 funds tracked by Wall St. Rank hold ITCI as of Q2 2025.

Alpine Global Management reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2025 after selling out during the quarter.
Alpine Global Management sold 50,000 Intra-Cellular Therapies Inc. shares in Q2 2025, an estimated $6.6M.
Alpine Global Management first reported a position in Intra-Cellular Therapies Inc. in Q2 2024 and held it in 2 quarters.
Alpine Global Management's Intra-Cellular Therapies Inc. position peaked at $6.6M in Q1 2025.
4 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2025.

Based on Alpine Global Management's 13F filing for Q2 2025, filed 14 Aug 2025.